ASP2215
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for ASP2215, covering 2019-02-15 to 2024-11-06. Get the full timeline:
Most recent: Clinical Trial Update: Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of ASP2215 in Japanese Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 1]